Clinical
RSSArticles
-
Empiric Anti-MRSA Therapy in Pneumonia May Not Always Be a Good Idea
In a retrospective cohort study, empiric anti-methicillin-resistant Staphylococcus aureus treatment was not associated with a reduction in mortality in any subgroup of patients studied and appeared to cause harm in many.
-
Investigators Uncover More Troubling Data About the Adverse Health Effects of Sugar-Sweetened Beverages
Recent study revealed women who consume just one such beverage per day were at a much higher risk for stroke and cardiovascular disease.
-
Early Data on Remdesivir for Severe COVID-19: A Promising Start?
In this group of patients hospitalized with severe COVID-19, the majority of whom required invasive ventilation, 68% showed clinical improvement after treatment with remdesivir on a compassionate-use basis.
-
Anticoagulation Therapy in Patients with Severe COVID-19
In a retrospective study involving 449 patients with severe COVID-19 requiring intensive care unit admission, those patients with a positive sepsis coagulation score or D-dimer greater than 3.0 mcg/mL who received prophylactic doses of low molecular weight heparin exhibited lower 28-day mortality.
-
Managing COVID-19 Respiratory Failure: Is There a Perfect Management Strategy?
COVID-19 is a systemic disease that primarily injures the vascular endothelium, causing a unique lung injury in which different management strategies may need to be considered to address the specific physiology of each patient.
-
Shipments of Remdesivir Begin Arriving at U.S. Hospitals
HHS requests facilities submit weekly data to facilitate distribution of the COVID-19 therapeutic.
-
Group Leads Charge Against Venous Thromboembolism
The American Heart Association issues guidance to help prevent a common and costly hospital-acquired condition.
-
Restricting Access to Abortion Increases Complications
Restrictive abortion laws increase the chance that a woman will self-manage her abortion, a practice associated with an increased risk of complications.
-
Should Metronidazole Be Added Routinely to Treatment Regimens for PID?
In this randomized, double-blind, controlled trial, routine treatment with metronidazole compared to placebo in addition to doxycycline and ceftriaxone reduced the presence of endometrial anaerobes, Mycoplasma genitalium, and pelvic tenderness at 30 days post-treatment. However, clinical improvement at three days post-treatment was no different between the two groups.
-
COVID-19 and Pregnancy: What Obstetricians Need to Know
While data remain limited on this particular coronavirus, extrapolation from other viruses (severe acute respiratory syndrome and Middle East respiratory syndrome), and best clinical observations and expert recommendations have led to current guidelines in care.